Prosecution Insights
Last updated: October 25, 2026

Cd Diagnostics Inc.

Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Cd Diagnostics Inc. currently has 2 pending office actions in the Transportation, E-Commerce & Mechanical Systems technology area. These active matters are split between 2 distinct examiners and 2 distinct art units, showing a complete diversification of its current prosecution workload. This means that every pending case is being handled by a different examiner in a different art unit.

The busiest examiner for the company is HRANEK, KAREN AMANDA, who is managing 1 pending office action. Since the busiest examiner pending count is 1 and there are 2 pending office actions in total, the workload is balanced between the 2 distinct examiners. This distribution ensures that no single examiner or art unit has a concentrated influence over the company's active portfolio.

For practitioners, this data suggests that Cd Diagnostics Inc. must manage 2 entirely separate prosecution tracks within the Transportation, E-Commerce & Mechanical Systems sector. With 2 pending office actions spread across 2 distinct art units and 2 distinct examiners, there is no overlap in the current review process. This requires a versatile strategy to address the specific requirements of 2 distinct examiners simultaneously.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
50% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HRANEK, KAREN AMANDA 1 34.7% +40.4%
FONSECA LOPEZ, FRANCINI ALVARENGA 1 28.6% +30.0%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18813597 METHODS AND TECHNIQUES FOR DIAGNOSING INFECTIONS HRANEK, KAREN AMANDA —
17573843 PRE-SURGICAL DIAGNOSTIC TOOL USING BIOMARKERS TO EVALUATE THE RISK FACTORS OF POST SURGICAL COMPLICATIONS FONSECA LOPEZ, FRANCINI ALVARENGA —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18813597 METHODS AND TECHNIQUES FOR DIAGNOSING INFECTIONS HRANEK, KAREN AMANDA —
17573843 PRE-SURGICAL DIAGNOSTIC TOOL USING BIOMARKERS TO EVALUATE THE RISK FACTORS OF POST SURGICAL COMPLICATIONS FONSECA LOPEZ, FRANCINI ALVARENGA —

Top Art Units

Art UnitApps
3684 1
1685 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18813597 METHODS AND TECHNIQUES FOR DIAGNOSING INFECTIONS HRANEK, KAREN AMANDA 3684 §103§112 Final Rejection — Pending Aug 23, 2024
17573843 PRE-SURGICAL DIAGNOSTIC TOOL USING BIOMARKERS TO EVALUATE THE RISK FACTORS OF POST SURGICAL COMPLICATIONS FONSECA LOPEZ, FRANCINI ALVARENGA 1685 §101§112 Non-Final OA — Pending Jan 12, 2022

Managing Cd Diagnostics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Cd Diagnostics Inc. have?

Cd Diagnostics Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Cd Diagnostics Inc. applications?

Karen Amanda Hranek has the most, with 1 of Cd Diagnostics Inc.'s pending office actions.

What technology area are Cd Diagnostics Inc.'s patent applications in?

Mostly Transportation, E-Commerce & Mechanical Systems (USPTO Tech Center 3600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month